Streetbeat News

Products Services

PBYI

Puma Biotechnology has received FDA approval to proceed under an IND for Alisertib, aimed at treating HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 12:32 pm

SILO

Silo Pharma has exercised an option for an exclusive license agreement to develop, manufacture, and commercialize a first-in-class therapeutic for PTSD and stress-induced anxiety. This move marks a significant step in the company's efforts to address mental health issues with innovative solutions.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 12:32 pm

AGFY

Agrify Corporation (AGFY) has secured a contract to provide turnkey solventless extraction equipment to Blackstone Valley Cannabis. Additionally, Blackstone Valley Cannabis has chosen Agrify's 6-day on-site Advanced Solvent Training Package for their staff training.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 12:27 pm

ACHV

Achieve Life Sciences announced that data from its Cytisinicline ORCA Program will be presented at the 2024 Society for Research on Nicotine and Tobacco Annual Meeting. This could indicate significant progress in their research and development efforts, potentially impacting the company's future prospects.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 12:24 pm

ONON

On Holding AG (NYSE:ONON) is set to open its first store in Hong Kong at H Queen's in Central District, amidst declining sales in China. The move is part of the company's strategy to expand and manage economic uncertainties, with Hong Kong's lower rents attracting luxury brands. Despite a 21.9% year-on-year sales growth in Q4 FY23 to CHF 447.1 million, On Holding missed analyst expectations. Shares of ONON saw a slight increase of 0.17% in premarket trading.

Portfolio Pulse from Shivani Kumaresan

March 20, 2024 | 12:24 pm

BCAN

ETAO

OBLG

OTRK

TSHA

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) shares surged 27.1% in pre-market trading after reporting a significant year-over-year decrease in FY23 losses and providing positive clinical updates. Other stocks also showed notable pre-market movements, with several companies experiencing significant gains or losses due to various factors such as financial results, business updates, and public offerings.

Portfolio Pulse from Avi Kapoor

March 20, 2024 | 12:20 pm

ALK

Alaska Airlines has introduced Alaska Access, a new subscription service offering exclusive deals including discounted Wi-Fi and other cost-saving benefits.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 12:20 pm

BTCUSD

CMG

ETHUSD

NVDA

TSLA

Cryptocurrencies Bitcoin, Ethereum, and Dogecoin experienced significant losses with $650M liquidated in a day, while a rally is predicted due to FOMO. US stocks face risks from de-dollarization, with Morgan Stanley expressing concern. Political developments include Trump vs. Biden dynamics heating up for 2024, with both securing key primary wins. In tech, Nvidia and Synopsys highlight their partnership's importance in chip design, and Tesla faces trade secret theft allegations. Consumer news includes Chipotle's stock split and Samsung's surge due to Nvidia's interest. Financially, BlackRock files for a tokenized asset fund, and Borse Dubai plans to sell its Nasdaq stake.

Portfolio Pulse from Akanksha Bakshi

March 20, 2024 | 12:18 pm

FEMY

Femasys announced positive topline data from its pivotal trial for FemaSeed, a treatment for infertility. In the severe male factor cohort, 24% of women achieved pregnancy with FemaSeed, which is more than double the historic rate for intrauterine insemination.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 12:18 pm

FOUR

The Los Angeles Rams have chosen Shift4's end-to-end payment solution to handle their ticketing transactions, aiming for a seamless fan experience.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 12:14 pm